These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27265006)

  • 1. Low Levels of Genetic Heterogeneity in Matched Lymph Node Metastases from Patients with Melanoma.
    Casula M; Colombino M; Manca A; Caracò C; Botti G; Ascierto PA; Lissia A; Cossu A; Palmieri G;
    J Invest Dermatol; 2016 Sep; 136(9):1917-1920. PubMed ID: 27265006
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumour mutation status and sites of metastasis in patients with cutaneous melanoma.
    Adler NR; Wolfe R; Kelly JW; Haydon A; McArthur GA; McLean CA; Mar VJ
    Br J Cancer; 2017 Sep; 117(7):1026-1035. PubMed ID: 28787433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRAF and NRAS mutations in Russian melanoma patients: results of a nationwide study.
    Frank GA; Aleksakhina SN; Zavalishina LE; Kekeyeva TV; Venina AR; Ivantsov AO; Mitiushkina NV; Moiseyenko AV; Pfeifer W; Strelkova TN; Imyanitov EN
    Melanoma Res; 2016 Oct; 26(5):442-7. PubMed ID: 27433783
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumour mutation status and melanoma recurrence following a negative sentinel lymph node biopsy.
    Adler NR; Wolfe R; McArthur GA; Kelly JW; Haydon A; McLean CA; Mar VJ
    Br J Cancer; 2018 May; 118(10):1289-1295. PubMed ID: 29755118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF, NRAS and MC1R status in a prospective series of primary cutaneous melanoma.
    García-Casado Z; Traves V; Bañuls J; Niveiro M; Gimeno-Carpio E; Jimenez-Sanchez AI; Moragón M; Onrubia JA; Oliver V; Kumar R; Nagore E
    Br J Dermatol; 2015 Apr; 172(4):1128-31. PubMed ID: 25385688
    [No Abstract]   [Full Text] [Related]  

  • 6. Is BRAF a prognostic factor in stage III skin melanoma? A retrospective study of 72 patients after positive sentinel lymph node dissection.
    Picard M; Pham Dang N; D'Incan M; Mansard S; Dechelotte P; Pereira B; Mondie JM; Barthelemy I
    Br J Dermatol; 2014 Jul; 171(1):108-14. PubMed ID: 24602025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node metastases of melanoma: challenges for BRAF mutation detection.
    Chen G; Dudley J; Tseng LH; Smith K; Gurda GT; Gocke CD; Eshleman JR; Lin MT
    Hum Pathol; 2015 Jan; 46(1):113-9. PubMed ID: 25456393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermoscopic features in BRAF and NRAS primary cutaneous melanoma: association with peppering and blue-white veil.
    Gouillon L; Perier-Muzet M; Amini-Adle M; Poulalhon N; Debarbieux S; Boespflug A; Balme B; Depaepe L; Harou O; Lopez J; Bringuier PP; Ferraro-Peyret C; Maucort-Boulch D; Robinson P; Thomas L; Dalle S
    J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):e57-e59. PubMed ID: 31442328
    [No Abstract]   [Full Text] [Related]  

  • 9. New observations in tumor cell plasticity: mutational profiling in a case of metastatic melanoma with biphasic sarcomatoid transdifferentiation.
    Rupp NJ; Rechsteiner M; Freiberger SN; Lenggenhager D; Urosevic M; Burger IA; Rushing EJ; Mihic-Probst D
    Virchows Arch; 2018 Oct; 473(4):517-521. PubMed ID: 29785541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic microenvironment of melanomas: Prognostic value of MCT1 and MCT4.
    Pinheiro C; Miranda-Gonçalves V; Longatto-Filho A; Vicente AL; Berardinelli GN; Scapulatempo-Neto C; Costa RF; Viana CR; Reis RM; Baltazar F; Vazquez VL
    Cell Cycle; 2016 Jun; 15(11):1462-70. PubMed ID: 27105345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric melanoma: the whole (genome) story.
    Pappo AS
    Am Soc Clin Oncol Educ Book; 2014; ():e432-5. PubMed ID: 24857134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case of Giant Primary Dermal Melanoma with BRAF V600E Mutation.
    Imamura T; Nakamura Y; Teramoto Y; Sato S; Asami Y; Arai E; Yamamoto A
    Acta Derm Venereol; 2016 Aug; 96(6):840-1. PubMed ID: 26984828
    [No Abstract]   [Full Text] [Related]  

  • 13. BRAF mutation screening in melanoma: is sentinel lymph node reliable?
    Nardin C; Puzenat E; Prétet JL; Algros MP; Doussot A; Puyraveau M; Mougin C; Aubin F
    Melanoma Res; 2015 Aug; 25(4):328-34. PubMed ID: 26020488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and genetic diversity in the metastatic process of melanoma.
    Harbst K; Lauss M; Cirenajwis H; Winter C; Howlin J; Törngren T; Kvist A; Nodin B; Olsson E; Häkkinen J; Jirström K; Staaf J; Lundgren L; Olsson H; Ingvar C; Gruvberger-Saal SK; Saal LH; Jönsson G
    J Pathol; 2014 May; 233(1):39-50. PubMed ID: 24399611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF mutation-positive folliculotropic metastatic melanoma.
    Brick KE; Halling KC; Khan YK; Peters MS
    Am J Dermatopathol; 2013 Jul; 35(5):609-12. PubMed ID: 23715079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unfolding the mutational landscape of human melanoma.
    Davar D; Lin Y; Kirkwood JM
    J Invest Dermatol; 2015 Mar; 135(3):659-662. PubMed ID: 25666674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma): Analysis of 14 Patients Emphasizing Phenotypic Plasticity and the Value of Molecular Testing as Surrogate Diagnostic Marker.
    Agaimy A; Specht K; Stoehr R; Lorey T; Märkl B; Niedobitek G; Straub M; Hager T; Reis AC; Schilling B; Schneider-Stock R; Hartmann A; Mentzel T
    Am J Surg Pathol; 2016 Feb; 40(2):181-91. PubMed ID: 26448190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vemurafenib as neoadjuvant treatment for unresectable regional metastatic melanoma.
    Koers K; Francken AB; Haanen JB; Woerdeman LA; van der Hage JA
    J Clin Oncol; 2013 Jun; 31(16):e251-3. PubMed ID: 23569313
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic profile of naïve untreated primary cutaneous melanomas with a negative sentinel lymph node.
    Yang K; Oh KS; Mahalingam M
    Clin Exp Dermatol; 2020 Dec; 45(8):1059-1062. PubMed ID: 32484959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microfluidic enrichment, isolation and characterization of disseminated melanoma cells from lymph node samples.
    Weidele K; Stojanović N; Feliciello G; Markiewicz A; Scheitler S; Alberter B; Renner P; Haferkamp S; Klein CA; Polzer B
    Int J Cancer; 2019 Jul; 145(1):232-241. PubMed ID: 30586191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.